MED30

MED30 is a metazoan-specific subunit of the Mediator transcriptional coactivator complex that is essential for both basal and activator-dependent RNA polymerase II transcription and for the structural integrity of the Mediator core. Cryo-EM structures place MED30 in the proximal tail module at the Head–Tail interface together with MED27, MED28, MED29, MED14, and MED17, and conditional deletion in cardiomyocytes destabilizes core Mediator subunits, causing rapid organ failure (PMID:33902108, PMID:34506481). MED30 controls tissue-specific transcriptional programs including oxidative phosphorylation and mitochondrial gene networks in the heart, cohesin recruitment to gene promoters, and MYC-dependent enhancer activation in cancer contexts (PMID:22106289, PMID:30796039, PMID:41965876). A hypomorphic Med30 missense mutation in mice causes progressive mitochondrial cardiomyopathy, establishing MED30 as a disease-relevant gene for cardiac metabolism (PMID:22106289).

1. 2002 High

   Establishing that MED30 (TRAP25) is an integral Mediator subunit required for transcription resolved its identity among the ~30 Mediator components and showed the complex is needed for both basal and activator-dependent RNA Pol II activity.

   Evidence Immunodepletion of TRAP25 from HeLa nuclear extract followed by in vitro transcription reconstitution

   PMID:11909976

   Open questions at the time

   • Role of MED30 within Mediator architecture not resolved
   • Contribution of MED30 versus other subunits to in vivo transcription unknown
   • No loss-of-function data in intact organisms
2. 2011 High

   A mouse hypomorphic Med30 mutation linked the subunit to a specific transcriptional program — oxidative phosphorylation and fatty acid oxidation in cardiomyocytes — moving understanding beyond a generic coactivator role to tissue-specific metabolic regulation.

   Evidence Mouse missense mutation causing progressive cardiomyopathy; expression profiling and ketogenic diet rescue

   PMID:22106289

   Open questions at the time

   • Direct target genes versus secondary effects not delineated
   • Mechanism by which MED30 selectively controls metabolic gene programs unclear
   • Whether human MED30 mutations cause cardiomyopathy not established
3. 2014 Medium

   Demonstrating that MED30 knockdown impairs HIV-1 post-integration transcription, including Tat-induced transcription, extended the subunit's functional scope to viral gene regulation.

   Evidence siRNA knockdown in HIV-infected cells with RT-PCR for viral transcripts

   PMID:25100719

   Open questions at the time

   • No direct physical interaction between MED30 and Tat demonstrated
   • Whether MED30 is specifically required or reflects general Mediator dependence not resolved
   • Not independently replicated in a second laboratory
4. 2019 Medium

   Genome-wide ChIP in Drosophila showed MED30 specifically directs cohesin and its loader Nipped-B to gene promoters, revealing a non-transcriptional structural role at chromatin distinct from enhancer-localized cohesin loading.

   Evidence ChIP-seq for MED30, Nipped-B, Rad21, SA in Drosophila cells with genetic analysis

   PMID:30796039

   Open questions at the time

   • Conservation of promoter-specific cohesin recruitment by MED30 in mammals not tested
   • Mechanism of physical coupling between MED30 and cohesin loader unknown
   • Functional consequence of promoter cohesin loss upon MED30 depletion not determined
5. 2021 High

   Cryo-EM of the human Mediator–PIC complex and conditional cardiac knockout together resolved MED30's structural position in the proximal tail module and demonstrated that loss of MED30 destabilizes the entire Mediator core in vivo, establishing it as a linchpin subunit.

   Evidence Cryo-EM of 50-subunit reconstituted human Mediator–PIC; cardiomyocyte-specific Med30 knockout with Western blot and RNA-seq

   PMID:33902108 PMID:34506481

   Open questions at the time

   • Atomic-resolution contacts between MED30 and neighboring subunits not fully resolved
   • Whether Mediator destabilization is the sole cause of transcriptional defects or MED30 has additional direct functions unresolved
   • Non-redundancy with neighboring proximal tail subunits only partially addressed
6. 2024 Medium

   Epistasis experiments showed MED27 overexpression cannot rescue MED30 loss and vice versa, establishing that MED30 and MED27 are independently required proximal tail subunits for Mediator stability — they are non-redundant despite proximity.

   Evidence Med27 cardiomyocyte-specific knockout with MED30 overexpression rescue, Western blot for Mediator subunits

   PMID:39209248

   Open questions at the time

   • Whether MED30 and MED27 stabilize overlapping or distinct subunit contacts not determined
   • Single laboratory finding
   • No structural data on the specific contacts each subunit contributes
7. 2024 Medium

   CRISPR screening in multiple myeloma and ChIP-seq in GBM/PDAC models converged on MED30 as a positive regulator of MYC expression and MYC-driven enhancer formation, implicating it as a specific node in oncogenic transcriptional rewiring.

   Evidence Genome-wide CRISPR screen with endogenous MYC-GFP reporter; ChIP-seq for MYC and epigenetic marks; in vivo tumor models (preprint for ChIP-seq data)

   PMID:38766212 PMID:41965876

   Open questions at the time

   • ChIP-seq/enhancer findings are from a preprint not yet peer-reviewed
   • Direct physical interaction between MED30 and MYC not demonstrated
   • Whether MED30's effect on MYC expression is direct transcriptional regulation or Mediator stability dependent is unclear

• How MED30 selectively controls tissue-specific transcriptional programs (metabolic, oncogenic, viral) despite being an apparently constitutive Mediator subunit remains the central unresolved mechanistic question.
• No activator-specific binding surface on MED30 has been mapped
• No separation-of-function mutations distinguishing structural versus regulatory roles exist
• Whether MED30's cohesin-recruiting function operates in mammals and contributes to gene regulation is untested